MicroStrategy
MSTR
Adobe
ADBE
Salesforce
CRM
Apple
AAPL
Meritage Homes
MTH
US Stock MarketDetailed Quotes
RPRX Royalty Pharma
- 24.920
- +0.640+2.64%
Close Dec 20 16:00 ET
- 25.010
- +0.090+0.36%
Post 20:01 ET
11.07BMarket Cap9.81P/E (TTM)
25.000High24.315Low7.57MVolume24.340Open24.280Pre Close188.55MTurnover1.95%Turnover Ratio9.85P/E (Static)444.30MShares30.92252wk High1.61P/B9.66BFloat Cap24.05052wk Low0.83Dividend TTM387.82MShs Float51.220Historical High3.33%Div YieldTTM2.82%Amplitude24.050Historical Low24.892Avg Price1Lot Size
Royalty Pharma Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 5.29%564.69M | -0.17%537.27M | -16.96%567.98M | 5.24%2.35B | 5.36%596.07M | -6.48%536.31M | 0.42%538.2M | 21.69%683.97M | -2.28%2.24B | -1.73%565.75M |
| Operating revenue | 5.29%564.69M | -0.17%537.27M | -16.96%567.98M | 5.24%2.35B | 5.36%596.07M | -6.48%536.31M | 0.42%538.2M | 21.69%683.97M | -2.28%2.24B | -1.73%565.75M |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | -144.27%-170.38M | -7.51%267.64M | 213.05%641.75M | -34.38%862.4M | -103.89%-16.83M | 0.95%384.87M | 82.95%289.36M | -40.12%205M | 53.05%1.31B | 2.44%432.58M |
| Selling and administrative expenses | -0.90%56.72M | 14.85%54.71M | -32.72%57.65M | 9.87%249.75M | -19.18%59.19M | 12.91%57.23M | -8.12%47.63M | 66.27%85.7M | 24.33%227.3M | 58.64%73.23M |
| -General and administrative expense | -0.90%56.72M | 14.85%54.71M | -32.72%57.65M | 9.87%249.75M | -19.18%59.19M | 12.91%57.23M | -8.12%47.63M | 66.27%85.7M | 24.33%227.3M | 58.64%73.23M |
| Research and development costs | -99.01%500K | 0.00%500K | 0.00%500K | -70.64%52M | -99.01%500K | 98.04%50.5M | -17.49%500K | -99.50%500K | -11.48%177.11M | -51.36%50.5M |
| Depreciation amortization depletion | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | -75.34%5.67M | --0 |
| -Depreciation and amortization | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | -75.34%5.67M | --0 |
| Other operating expenses | -182.13%-227.6M | -11.94%212.43M | 391.23%583.6M | -38.00%560.66M | -124.77%-76.51M | -9.15%277.14M | 128.19%241.23M | -35.65%118.8M | 99.68%904.24M | 15.89%308.85M |
| Operating profit | 385.38%735.07M | 8.35%269.63M | -115.40%-73.77M | 61.68%1.49B | 360.23%612.9M | -21.21%151.44M | -34.13%248.84M | 117.99%478.97M | -35.49%922.89M | -13.20%133.17M |
| Net non-operating interest income expense | -116.83%-49M | -67.32%-35.63M | -21.71%-36.82M | -4.81%-114.9M | -1,213.83%-40.76M | 31.41%-22.6M | 40.92%-21.3M | 19.41%-30.25M | 2.65%-109.63M | 91.46%-3.1M |
| Non-operating interest income | -25.29%17.51M | -47.84%13.38M | -55.59%7.42M | -7.72%72.29M | -85.18%6.5M | 66.99%23.44M | 134.94%25.65M | 75.28%16.7M | 46.32%78.34M | 312.19%43.85M |
| Non-operating interest expense | 44.47%66.51M | 4.40%49.01M | -5.79%44.23M | -0.41%187.19M | 0.64%47.26M | -2.01%46.03M | -0.04%46.95M | -0.24%46.95M | 13.13%187.96M | -0.04%46.96M |
| Other net income (expense) | 1,877.22%120.28M | -132.01%-39.62M | 76.12%106.32M | 155.36%322.83M | 119.65%145.45M | -111.07%-6.77M | -17.39%123.79M | 211.58%60.37M | -658.32%-583.2M | -1,067.15%-740.1M |
| Gain on sale of security | 69,172.67%111.53M | -138.33%-47.32M | 334.52%124.15M | 460.20%315.69M | 240.63%163.49M | -99.79%161K | -17.77%123.47M | 154.17%28.57M | 208.92%56.35M | -465.18%-116.25M |
| Earnings from equity interest | 299.29%10.41M | 321.17%1.7M | -140.89%-14.15M | 421.88%28.88M | 103.91%268K | -60.63%-5.22M | -204.48%-770K | 8,616.88%34.61M | 53.96%-8.97M | 81.97%-6.86M |
| Special income (charges) | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---615.83M | ---- |
| -Write off | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --615.83M | ---- |
| Other non- operating income (expenses) | 3.10%-1.65M | 449.95%6M | -31.00%-3.69M | -47.32%-21.74M | -1,471.50%-18.31M | 84.19%-1.71M | 205.41%1.09M | -60.10%-2.81M | -159.86%-14.76M | 75.83%-1.17M |
| Income before tax | 560.53%806.36M | -44.67%194.38M | -100.84%-4.27M | 638.96%1.7B | 217.63%717.59M | -44.61%122.08M | -28.53%351.34M | 297.47%509.09M | -81.46%230.06M | -1,236.61%-610.03M |
| Income tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income | 560.53%806.36M | -44.67%194.38M | -100.84%-4.27M | 638.96%1.7B | 217.63%717.59M | -44.61%122.08M | -28.53%351.34M | 297.47%509.09M | -81.46%230.06M | -1,236.61%-610.03M |
| Net income continuous Operations | 560.53%806.36M | -44.67%194.38M | -100.84%-4.27M | 638.96%1.7B | 217.63%717.59M | -44.61%122.08M | -28.53%351.34M | 297.47%509.09M | -81.46%230.06M | -1,236.61%-610.03M |
| Minority interest income | 425.13%262.37M | -25.33%92.37M | -105.38%-9.05M | 201.90%565.25M | 245.02%223.25M | -35.75%49.96M | -33.88%123.71M | 120.56%168.33M | -69.87%187.23M | -436.37%-153.95M |
| Net income attributable to the parent company | 654.34%543.99M | -55.19%102M | -98.60%4.78M | 2,549.50%1.13B | 208.39%494.34M | -49.45%72.11M | -25.25%227.63M | 558.32%340.76M | -93.09%42.83M | -5,870.29%-456.08M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | -392.73M | |||||||||
| Net income attributable to common stockholders | 654.34%543.99M | -55.19%102M | -98.60%4.78M | 3,466.40%1.53B | 294.50%887.07M | -49.45%72.11M | -25.25%227.63M | 558.32%340.76M | -93.09%42.83M | -5,870.29%-456.08M |
| Basic earnings per share | 662.50%1.22 | -54.90%0.23 | -98.68%0.01 | 2,440.00%2.54 | 206.73%1.11 | -50.00%0.16 | -27.14%0.51 | 533.33%0.76 | -93.29%0.1 | -1.04 |
| Diluted earnings per share | 656.25%1.21 | -54.00%0.23 | -98.68%0.01 | 2,430.00%2.53 | 174.96%1.1 | -50.00%0.16 | -28.57%0.5 | 533.33%0.76 | -93.29%0.1 | -122.01%-1.4675 |
| Dividend per share | 5.00%0.21 | 5.00%0.21 | 5.00%0.21 | 5.26%0.8 | 5.26%0.2 | 5.26%0.2 | 5.26%0.2 | 5.26%0.2 | 11.76%0.76 | 11.76%0.19 |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | -- | -- |
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.